Services
Methodology
Resources
About
Contact
Request Assessment

Resources & Insights

RelyAInt provides structured resources designed to support regulated organisations in strengthening validation programs, improving data integrity governance, and maintaining inspection readiness.

Practical guidance for pharmaceutical, biotech, and medical device environments.

Validation & CSV

Protocols, risk-based validation guidance, and inspection-ready approaches.

Data Integrity

ALCOA+ principles, governance models, and practical audit readiness guidance.

GxP Compliance

Quality frameworks, regulated documentation practices, and operational assurance.

Regulatory Readiness

GAP assessment insights, inspection preparation tools, and common findings.

Featured Tools & Downloads

CSV Readiness Checklist

(PDF)
Assess your computerized systems against technical and regulatory requirements before beginning the validation process. This checklist helps identify infrastructure gaps to ensure a smooth, compliant deployment.
Download PDF Checklist

Data Integrity Audit Checklist

(PDF)
Evaluate your data lifecycle management using the core ALCOA+ principles. It provides a structured framework to verify that your electronic records are secure, traceable, and inspection-ready.
Download PDF Checklist

GAP Assessment Summary Template

(DOCX)
Bridge the divide between your current operations and full GxP compliance with this editable document. Use it to categorize identified risks and outline a clear roadmap for remediation.
Download PDF Template

Latest Insights

Top 10 Data Integrity Findings in Pharma

Regulatory agencies are sharpening their focus on data reliability more than ever before. Discover the most common pitfalls found in recent warning letters and learn how to bulletproof your records against similar scrutiny.

Read More

What Inspectors Expect From CSV Documentation

A clean system is only as good as the paper trail that proves it. We break down the specific evidence, signatures, and trace maps inspectors look for to ensure your computerized systems are truly “under control.”

Read More

How to Structure a Risk-Based Validation Plan

Don’t waste resources validating every minor feature; focus your efforts where they actually impact patient safety and product quality. Learn the strategic framework for a lean, defensible validation plan that satisfies both auditors and your budget.

Read More

GAMP 5 Explained for Modern Systems

As technology evolves toward Cloud and AI, the industry standard for GxP software must follow suit. Explore how the latest GAMP 5 principles apply to agile environments and automated workflows without compromising compliance.

Read More

Need Support With Your Compliance Priorities?

If you would like structured advisory support or a rapid compliance assessment, our team is available for confidential engagement discussions.

Request Assessment

Top 10 Data Integrity Findings in Pharma

What regulators commonly identify — and how to prevent critical observations.

Approx. 4–6 min read • For QA, QC, Validation, IT, and System Owners

What inspectors see:

Shared logins, generic accounts (e.g., “LabUser”), and poorly controlled admin access remain one of the most frequent red flags.

Why it matters:

If actions cannot be attributed to an individual, the integrity of the entire dataset becomes questionable.

The Target Operating State:

  • Unique user accounts for all personnel

  • Role-based access control (RBAC)

  • Admin access restricted and justified

  • Periodic access reviews performed and documented

What inspectors see:

Audit trails exist, but no one reviews them — or reviews are done informally with no evidence.

Why it matters:

Audit trails are only effective when they are actively monitored to detect abnormal activity, unauthorized changes, and data manipulation.

The Target Operating State:

  • Audit trail review SOP exists

  • Review performed at defined intervals

  • Evidence of review is retained

  • Abnormal events are investigated

What inspectors see:

Only summary reports are retained, while raw data files, original electronic records, or metadata are missing.

Why it matters:

Inspectors expect complete traceability back to the original record. Without raw data, results may be considered unreliable.

The Target Operating State:

  • Raw data retention defined and enforced

  • Metadata preserved (timestamps, users, change history)

  • Archived records remain retrievable

What inspectors see:

Operators generate results in systems, then transfer data into spreadsheets, paper notes, or uncontrolled templates for review or calculations.

Why it matters:

Uncontrolled manual transfer introduces risk of transcription errors and manipulation.

The Target Operating State:

  • Controlled workflows

  • Approved templates

  • Second-person verification for transcription

  • Data flow mapping and control

What inspectors see:

Critical calculations, batch release decisions, or QC trending performed in Excel files without protection, version control, or validation.

Why it matters:

Spreadsheets are extremely high risk when used as decision-making tools without governance.

The Target Operating State:

  • Spreadsheet inventory

  • Risk classification of spreadsheets

  • Version control and access restriction

  • Formula protection and validation where required

What inspectors see:

System administrators can modify data and also approve records, or analysts can review and approve their own work.

Why it matters:

This creates opportunity for intentional or unintentional manipulation without detection.

The Target Operating State:

  • Segregation between entry, review, approval roles

  • Admin activities logged and reviewed

  • Privileged access controlled and justified

What inspectors see:

Records show suspicious timestamps, missing entries, overwritten values, or changes without justification.

Why it matters:

Regulators treat unexplained changes as a serious integrity risk.

The Target Operating State:

  • Change reasons required in systems

  • Audit trail review detects abnormal patterns

  • Investigations performed and documented

What inspectors see:

Deviations are closed quickly without root cause analysis, and DI issues are treated as minor documentation errors.

Why it matters:

Inspectors expect DI issues to be treated as systemic quality risks.

The Target Operating State:

  • DI incidents escalated to QA

  • Root cause analysis performed

  • CAPA implemented and effectiveness verified

  • Impact assessment includes product quality and patient safety

What inspectors see:

Backups exist, but no evidence of restore testing is available.

Why it matters:

A backup is not valid until restore is proven. Loss of data is considered a compliance failure.

The Target Operating State:

  • Backup SOP exists

  • Restore testing performed routinely

  • Restore evidence documented and retained

  • Disaster recovery plan established

What inspectors see:

Organisations have SOPs that look compliant, but operations do not follow them.

Why it matters:

Regulators assess what is actually happening on the floor, not what is written in binders.

The Target Operating State:

  • SOPs aligned to real workflows

  • Training effectiveness checks

  • Internal audits confirm execution

  • Routine quality oversight and trending

Key Takeaway

Data integrity failures rarely occur due to a single issue. They are typically caused by weak governance, inconsistent oversight, and lack of effective monitoring controls.

A strong data integrity program is not about “having policies” – it is about ensuring evidence exists, controls are effective, and abnormal activity is detected early.

 

How RelyAInt Can Help

At RelyAInt, we support pharmaceutical organizations through structured advisory services including:

  • Data Integrity GAP Assessments

  • Audit Trail Review Frameworks

  • Spreadsheet Governance Models

  • CSV / Validation Readiness Reviews

  • Inspection Readiness Support

If you would like a confidential advisory discussion, our team is available to support.

Request an Assessment

Want the full checklist?

Download the Data Integrity Readiness Checklist (ALCOA+) and use it as a structured screening tool.
Download DI Checklist

What Inspectors Expect From CSV Documentation

Understanding the validation evidence regulators actually review during inspections.
 
Approx. 5 min read • QA • Validation • IT • System Owners

What inspectors look for

Inspectors expect organizations to clearly demonstrate why a computerized system is used within a GxP process.

Common observation

Systems validated technically but without documented business purpose.

Inspection-ready expectation

  • Intended use documented

  • GxP impact defined

  • System boundaries understood

  • Critical functions identified

What inspectors look for

Evidence that validation effort matches system risk and complexity.

Common observation

Over-testing low-risk systems or insufficient testing of critical functionality.

Inspection-ready expectation

  • Formal risk assessment

  • Critical functions identified

  • Testing scope justified

  • Risk drives validation depth

What inspectors look for

Proof that requirements were actually verified.

Common observation

URS documents exist but cannot be traced to testing evidence.

Inspection-ready expectation

  • Requirements Traceability Matrix (RTM)

  • URS mapped to test scripts

  • Critical requirements verified

  • Deviations linked to requirements

What inspectors look for

A logical validation story from planning to release.

Common observation

Missing lifecycle continuity between documents.

Inspection-ready expectation

  • Validation Plan

  • Risk Assessment

  • IQ/OQ/PQ or equivalent testing

  • Validation Summary Report

  • Formal release approval

Inspectors should be able to follow validation chronologically.

What inspectors look for

Evidence that the validated configuration is known and controlled.

Common observation

Validated systems change without documentation.

Inspection-ready expectation

  • System configuration documented

  • Version control maintained

  • Infrastructure defined

  • Changes governed via change control

What inspectors look for

Confirmation that data integrity controls were tested — not assumed.

Common observation

Audit trail functionality enabled but never validated.

Inspection-ready expectation

  • Audit trail testing performed

  • Access controls verified

  • Role permissions tested

  • Electronic signatures verified (where applicable)

What inspectors look for

Understanding of vendor responsibility vs regulated company responsibility.

Common observation

Organizations relying entirely on vendor validation claims.

Inspection-ready expectation

  • Supplier qualification

  • Vendor documentation review

  • Defined shared responsibilities

  • SaaS/cloud governance understanding

What inspectors look for

Proof the system remains validated over time.

Common observation

Validation treated as a one-time activity.

Inspection-ready expectation

  • Changes assessed for validation impact

  • Regression testing where required

  • Patch governance

  • Configuration change traceability

What inspectors look for

Ongoing assurance of validated state.

Common observation

Validated systems never reviewed post-implementation.

Inspection-ready expectation

Periodic review confirming:

  • system performance

  • access control review

  • audit trail review expectations

  • incident/deviation trends

What inspectors look for

Speed and clarity of evidence retrieval.

Common observation

Validation documents exist but are scattered.

Inspection-ready expectation

Inspectors should be able to obtain within hours:

  • Validation summary

  • Test evidence

  • Risk assessments

  • Change history

  • Training evidence

Key Takeaway

CSV inspections rarely fail due to missing documents — they fail because validation evidence does not demonstrate control, traceability, or lifecycle governance.

Strong CSV documentation tells a coherent validation story, not just a collection of protocols.

 

How RelyAInt Can Help

At RelyAInt, we support pharmaceutical organizations through structured advisory services including:

  • Data Integrity GAP Assessments

  • Audit Trail Review Frameworks

  • Spreadsheet Governance Models

  • CSV / Validation Readiness Reviews

  • Inspection Readiness Support

If you would like a confidential advisory discussion, our team is available to support.

Request an Assessment

Assess Your CSV Readiness

Use our Computerized System Validation (CSV) Readiness Checklist to identify validation gaps before inspection.
Download CSV Readiness Checklist

How to Structure a Risk-Based Validation Plan

A practical framework for aligning computerized system validation effort with regulatory risk expectations.

Approx. 5–6 min read • QA • Validation • IT • System Owners

What inspectors expect

Validation planning begins with a clear understanding of how the system impacts GxP processes.

Common mistake

Validation plans created using generic templates without defining operational purpose.

Inspection-ready approach

  • Clearly define intended use

  • Identify GxP impact

  • Define system boundaries

  • Document included and excluded functionality

Risk assessment cannot occur without defined scope.

What inspectors expect

Evidence that systems affecting product quality, patient safety, or data integrity receive appropriate validation control.

Common mistake

All systems treated equally regardless of risk.

Inspection-ready approach

Determine whether the system:

  • Supports GMP decisions

  • Generates or manages regulated data

  • Influences batch release or quality decisions

  • Maintains electronic records

Only GxP-impacting systems require full validation effort.

What inspectors expect

Validation effort justified through documented risk evaluation.

Common mistake

Risk assessments performed after validation instead of driving it.

Inspection-ready approach

Assess risks related to:

  • System functionality

  • Data integrity exposure

  • Process criticality

  • User interaction

  • Automation level

  • Interface dependencies

Risk outcomes should directly determine testing scope.

What inspectors expect

Validation depth aligned with system criticality.

Common mistake

Executing IQ/OQ/PQ mechanically for every system.

Inspection-ready approach

Higher-risk systems require:

  • Expanded functional testing

  • Data integrity verification

  • Negative testing scenarios

  • Enhanced documentation review

Lower-risk systems may justify:

  • Leveraging supplier testing

  • Reduced execution testing

  • Configuration verification

What inspectors expect

Proof that critical requirements were verified.

Common mistake

Testing disconnected from requirements.

Inspection-ready approach

  • Approved URS defining intended use

  • Identification of critical requirements

  • Traceability matrix linking:

    • requirements

    • risk controls

    • test cases

    • results

Traceability demonstrates control.

What inspectors expect

A coherent validation lifecycle — not isolated documents.

Inspection-ready structure

A risk-based validation plan typically defines:

  • Validation Plan

  • Risk Assessment

  • Requirements Documentation

  • Test Protocols (IQ/OQ/PQ or equivalent)

  • Deviation Management

  • Validation Summary Report

  • System Release Authorization

Inspectors should see logical progression.

What inspectors expect

Understanding of vendor contribution to validation assurance.

Common mistake

Assuming vendor validation eliminates responsibility.

Inspection-ready approach

  • Supplier qualification

  • Vendor documentation review

  • Cloud/SaaS hosting assessment

  • Infrastructure dependency evaluation

  • Responsibility matrix definition

Regulated companies retain ultimate accountability.

What inspectors expect

Evidence systems remain validated after go-live.

Common mistake

Validation treated as a one-time project.

Inspection-ready approach

Validation plan should define:

  • Change impact assessment

  • Patch governance

  • Regression testing expectations

  • Configuration control

  • Periodic review requirements

Validation is lifecycle governance.

What inspectors expect

Clear justification for system release.

Common mistake

Systems released without formal acceptance criteria.

Inspection-ready approach

  • Defined acceptance criteria

  • Deviation resolution or justification

  • Residual risk acceptance

  • QA approval prior to GxP use

Release decisions must be defensible.

What inspectors expect

Rapid demonstration of validation control.

Inspection-ready approach

Validation plan should ensure:

  • Evidence is structured and retrievable

  • Roles and responsibilities are clear

  • Risk rationale is documented

  • Validation story is understandable

Inspectors evaluate clarity as much as completeness.

Key Takeaway

Risk-based validation is not about reducing documentation – it is about applying validation efforts intelligently to protect product quality, patient safety, and data integrity.

A well-structured validation plan demonstrates control before testing even begins.

 

How RelyAInt Can Help

At RelyAInt, we support pharmaceutical organizations through structured advisory services including:

  • Data Integrity GAP Assessments

  • Audit Trail Review Frameworks

  • Spreadsheet Governance Models

  • CSV / Validation Readiness Reviews

  • Inspection Readiness Support

If you would like a confidential advisory discussion, our team is available to support.

Request an Assessment

Assess Your CSV Validation Strategy

Use our Computerized System Validation (CSV) Readiness Checklist to evaluate whether your validation approach aligns with risk-based regulatory expectations.
Download CSV Readiness Checklist

GAMP 5 Explained for Modern Systems

How risk-based validation principles apply to today’s cloud, SaaS, and configurable platforms.

Approx. 6 min read • QA • Validation • IT • Digital Transformation Leaders

Common misconception

GAMP 5 is often interpreted as a documentation framework requiring IQ/OQ/PQ for every system.

Reality

GAMP 5 is fundamentally about:

  • Risk-based assurance
  • Leveraging supplier activities
  • Applying effort proportional to risk

 

The goal is fitness for intended use, not documentation volume.

Before validation begins, organisations must determine:

Does this system impact GxP activities, product quality, patient safety, or regulated data?

This decision drives everything that follows.

What inspectors commonly see

  • Validation started before impact assessment

  • All systems validated equally

  • Business tools treated as GxP systems unnecessarily

  • SaaS platforms over- or under-validated

Inspection-ready approach

An Initial GxP Impact Assessment should determine whether the system:

  • Supports GMP or quality decisions

  • Generates or manages regulated records

  • Impacts batch release or laboratory results

  • Maintains electronic records/signatures

  • Influences data used for compliance decisions

 

Outcome of the assessment

ResultValidation Expectation
Non-GxPNo formal CSV required
Indirect ImpactLimited assurance controls
Direct GxP ImpactFull risk-based validation

This step prevents both over-validation and regulatory exposure.

GAMP 5 categorisation helps determine validation approach:

  • Category 1 — Infrastructure

  • Category 3 — Non-configured software

  • Category 4 — Configured applications

  • Category 5 — Custom applications

Modern SaaS systems typically fall into:

Configured applications (Category 4)

Meaning validation focuses on:

  • configuration

  • intended use

  • interfaces

  • data integrity controls

– not software code testing.

GAMP 5 expects risk to define:

  • Documentation depth

  • Testing scope

  • Verification activities

  • Review rigor

Higher risk = deeper assurance.

Lower risk = supplier leverage.

Risk assessment should occur before validation planning.

Modern systems rely heavily on vendors.

GAMP 5 allows organizations to leverage:

  • Supplier SDLC evidence

  • Vendor testing

  • Release documentation

  • Certifications

However:

Accountability for compliance always remains with the regulated company.

GAMP 5 promotes testing what matters most:

Inspectors expect verification of:

  • Critical workflows

  • Data integrity controls

  • Access permissions

  • Audit trails

  • Electronic signatures

Testing every feature is unnecessary.

Validation does not end at go-live.

Modern GAMP 5 lifecycle includes:

  • Change control

  • Patch governance

  • Periodic review

  • Access review

  • Incident monitoring

Systems must remain in a validated state.

Modern expectations include:

  • Understanding hosting responsibility

  • Reviewing vendor controls

  • Assessing infrastructure dependency

  • Managing configuration changes

  • Monitoring vendor update

 

Validation shifts from installation testing → governance oversight.

Inspectors expect coherence:

  • Intended Use

  • GxP Impact Assessment

  • Risk Assessment

  • Requirements

  • Testing

  • Release Decision

Documents should explain why controls exist, not just prove execution.

Inspectors are assessing confidence:

Can the organisation demonstrate that:

  • Risks were understood,

  • Controls were applied intelligently,

  • And the system remains governed?

GAMP 5 success = demonstrated control.

Key Takeaway

GAMP 5 is not a validation methodology – it is a risk-based decision framework.
The Initial GxP Impact Assessment is the most critical step, because it determines the level of assurance required for the entire system lifecycle.

 

How RelyAInt Can Help

At RelyAInt, we support pharmaceutical organizations through structured advisory services including:

  • Data Integrity GAP Assessments

  • Audit Trail Review Frameworks

  • Spreadsheet Governance Models

  • CSV / Validation Readiness Reviews

  • Inspection Readiness Support

If you would like a confidential advisory discussion, our team is available to support.

Request an Assessment

Evaluate Your CSV Strategy Against GAMP 5 Principles

Use our Computerized System Validation (CSV) Readiness Checklist to determine whether your validation approach aligns with modern GAMP 5 expectations.
Download CSV Readiness Checklist

Request an Advisory Discussion

Please complete the structured intake form below. This allows our team to confirm scope, regulatory context, and advisory fit. All submissions are reviewed by qualified professionals.

Confidential. No obligation. Response within 24–48 hours.
AI tools may support drafting only. Compliance conclusions are human verified.

Privacy Policy

Effective Date: 15-Jan-26
Website: https://relyaint.com
Operator: Relyaint Advisory Services (“Relyaint”, “we”, “our”, or “us”)

RelyAInt respects your privacy and is committed to protecting personal information collected through this website.

This Privacy Policy explains how we collect, use, store, and protect personal data when you visit our website or interact with our services.

We may collect the following categories of information:

a) Information You Provide Directly

When submitting forms, downloading resources, or contacting us, you may provide:

  • Full name

  • Email address

  • Company name

  • Job title or role

  • Country or region

  • Business enquiry information

  • Messages or comments voluntarily submitted

When visiting our website, certain technical information may be collected automatically, including:

  • IP address

  • Browser type

  • Device information

  • Pages visited

  • Website interaction data

  • Referral source

This information helps improve website performance and user experience.

We use collected information to:

  • Respond to enquiries and requests

  • Provide access to downloadable resources

  • Deliver advisory communications

  • Improve website functionality and content

  • Understand visitor engagement

  • Provide relevant professional insights

  • Maintain security and prevent misuse

We do not sell personal data.

Where applicable under data protection laws (including GDPR), personal information is processed based on:

  • User consent

  • Legitimate business interests

  • Performance of requested services

  • Compliance with legal obligations

Forms on this website may be powered by third-party platforms, including Airtable, used to securely collect and manage enquiry and resource request information.

Information submitted through forms is stored within controlled cloud environments and accessed only for legitimate business purposes.

Users should avoid submitting confidential manufacturing or regulated operational data unless a formal engagement agreement is in place.

This website may use cookies or similar technologies to:

  • analyse website traffic,

  • improve usability,

  • understand visitor behaviour.

Cookies do not typically identify individuals directly.

Users may disable cookies through their browser settings.

We may share information with trusted service providers solely for operational purposes, including:

  • website hosting providers,

  • analytics services,

  • secure data storage platforms,

  • communication tools.

Personal information is never sold or distributed for marketing resale purposes.

As RelyAInt operates globally, information may be processed or stored in cloud systems located outside your country of residence.

Reasonable safeguards are implemented to ensure appropriate protection of personal data.

Personal information is retained only for as long as necessary to:

  • respond to enquiries,

  • maintain business communications,

  • comply with legal or professional obligations.

Users may request deletion of their information at any time.

RelyAInt implements reasonable administrative and technical safeguards to protect personal information from unauthorized access, disclosure, or misuse.

However, no internet transmission method can be guaranteed to be completely secure.

Depending on applicable laws, users may have the right to:

  • request access to personal data,

  • request correction of inaccurate information,

  • request deletion of personal information,

  • withdraw consent,

  • object to processing.

Requests may be submitted using the contact information below.

This website may contain links to external websites.

RelyAInt is not responsible for the privacy practices or content of third-party websites.

This website is intended for professional and business audiences.

RelyAInt does not knowingly collect personal data from individuals under the age of 18.

This Privacy Policy may be updated periodically.

Updated versions will be published on this page with a revised effective date.

For privacy-related enquiries or data requests

RelyAInt Advisory Services
Email: Support@relyaint.com
Website: https://relyaint.com

Terms of Use

Effective Date: 15-Jan-26
Website: https://relyaint.com
Operator: Relyaint Advisory Services (“Relyaint”, “we”, “our”, or “us”)

By accessing or using this website, including any materials, resources, downloads, or advisory content provided through it, you agree to be bound by these Terms of Use.

If you do not agree with these Terms, you should discontinue use of this website immediately.

This website provides informational materials, advisory insights, and readiness resources related to:

  • GxP compliance

  • Computerized System Validation (CSV)

  • Data Integrity

  • Quality and Validation Governance

  • Regulatory and inspection readiness

All information is provided for general informational and advisory purposes only.

Content provided through this website, including downloadable checklists, insights, templates, or AI-assisted outputs:

  • does not constitute regulatory approval,

  • does not represent a compliance certification,

  • does not replace qualified professional judgment,

  • does not guarantee inspection outcomes.

Users remain solely responsible for determining regulatory applicability within their organization.

All resources made available on this website are provided as advisory tools intended to support internal assessment and improvement activities.

Use of these materials does not create a consultant–client relationship unless a formal written agreement has been executed between RelyAInt and the user.

RelyAInt may utilize artificial intelligence tools to assist in drafting, summarising, or structuring advisory content.

AI systems are used solely as supportive tools.

Relyaint maintains human oversight and review, and AI systems do not independently determine compliance status, risk classification, or regulatory conclusions.

All website content, including but not limited to:

  • text

  • methodologies

  • checklists

  • frameworks

  • downloadable resources

  • branding and design

  • advisory materials

are the intellectual property of RelyAInt unless otherwise stated.

Users may:

  • download materials for internal organizational use.

Users may not:

  • reproduce,

  • distribute,

  • modify,

  • resell,

  • publish,

  • or commercially exploit materials

without prior written permission from RelyAInt.

Downloadable materials are provided for:

  • Internal business evaluation

  • Readiness screening

  • Educational purposes

They may not be:

  • Redistributed externally,

  • Incorporated into commercial consulting offerings,

  • Presented as proprietary methodologies.

To the maximum extent permitted by applicable law, RelyAInt shall not be liable for any direct, indirect, incidental, or consequential damages arising from:

  • reliance on website content,

  • use of downloadable materials,

  • interpretation of advisory information,

  • regulatory or inspection outcomes.

All use of the website and its materials is at the user’s own risk.

This website may contain links to third-party websites or services.

RelyAInt is not responsible for the content, security, or privacy practices of external sites.

Information submitted through website forms or intake processes will be treated as confidential and used solely for responding to enquiries or providing advisory services, subject to our Privacy Policy.

Users should not submit confidential manufacturing or regulated data unless a formal engagement agreement is in place.

All materials are provided “as is” without warranties of any kind, including accuracy, completeness, or fitness for a particular purpose.

Regulatory expectations may change, and users are responsible for confirming current applicability.

Relyaint reserves the right to modify these Terms of Use at any time.

Updated terms will be posted on this page with a revised effective date.

Continued use of the website constitutes acceptance of updated terms.

These Terms shall be governed and interpreted in accordance with the laws of: Republic of South Africa without regard to conflict of law principles.

For questions regarding these Terms of Use, please contact:

RelyAInt Advisory Services
Email: Support@relyaint.com
Website: https://relyaint.com

Cookie Policy

Effective Date: 15-Jan-26
Website: https://relyaint.com
Operator: Relyaint Advisory Services (“Relyaint”, “we”, “our”, or “us”)

This Cookie Policy explains how RelyAInt uses cookies and similar technologies when you visit our website.

Cookies help us improve website functionality, understand visitor interaction, and provide a secure and efficient browsing experience.

By continuing to use this website, you consent to the use of cookies as described in this policy.

Cookies are small text files stored on your device when visiting a website.

They allow websites to recognise user devices and remember certain information about visits, preferences, or interactions.

Cookies do not typically identify individuals directly.

a) Essential Cookies

These cookies are necessary for website functionality and security.

They enable:

  • page navigation,

  • secure form submission,

  • website performance stability,

  • session management.

The website may not function correctly without these cookies.

b) Performance and Analytics Cookies

These cookies help us understand how visitors interact with our website.

They may collect information such as:

  • pages visited,

  • time spent on pages,

  • navigation behavior,

  • general geographic region,

  • device or browser type.

This information is aggregated and used solely to improve website performance.

c) Functional Cookies

Functional cookies remember user preferences such as:

  • display settings,

  • navigation behavior,

  • previously visited pages.

These improve usability but are not strictly required.

d) Third-Party Service Cookies

Certain features on this website rely on trusted third-party providers, which may set cookies, including:

  • website hosting services,

  • analytics platforms,

  • embedded forms or integrations (such as Airtable),

  • security and performance tools.

Relyaint does not control cookies set by third-party services.

Cookies may be used to:

  • ensure proper website operation,

  • improve user experience,

  • analyse traffic trends,

  • monitor website performance,

  • enhance security,

  • support resource downloads and form submissions.

Cookies are not used for selling personal data.

Users may control or disable cookies through browser settings.

Most browsers allow users to:

  • block cookies,

  • delete stored cookies,

  • receive alerts before cookies are stored.

Disabling cookies may impact website functionality.

Where required by applicable data protection laws, visitors may be presented with a cookie notice or consent banner when first accessing the website.

Continued use of the website after consent indicates acceptance of cookie usage.

Information collected through cookies is handled in accordance with our Privacy Policy.

For further information on how personal data is managed, please refer to:

  • Privacy Policy

This Cookie Policy may be updated periodically to reflect changes in technology or regulatory requirements.

Updated versions will be published on this page with a revised effective date.

For questions regarding this Cookie Policy:

RelyAInt Advisory Services
Email: Support@relyaint.com
Website: https://relyaint.com